返回 Agenda
Session Chair(s)
Richard Stephens, MA
Past Chair, Consumer Forum
National Cancer Research Institute (NCRI), United Kingdom
Learning Objective : • Describe how and when patient involvement occurs during the EMA and FDA regulatory processes • Explain the process for selecting, screening and training patients/caregivers for involvement • Describe the EMA/FDA fellowship exchange • Identify areas where EMA/FDA could enhance their engagement with patients • Outline EMA/FDA areas of collaboration on patient involvement
Speaker(s)
PaCe’ing Medical Affairs
Guy Yeoman
AstraZeneca, United Kingdom
Vice President Patient Centricity
How the BMJ is Co-Creating Content with Patients
Tessa Richards
BMJ, United Kingdom
Senior Editor / Patient Parnerships
EMA/FDA Patient Engagement – Comparing and Sharing
Nathalie Bere, MPH
European Medicines Agency, Netherlands
Patient Engagement
A Meaningful Future of the Patient Information Leaflet in Europe
Aimad Torqui
MEB, Netherlands
Head of Division European cooperation and veterinary affairs